Merus N.V. Announces Proposed Public Offering of Common Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/4/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Merus N.V. (MRUS) PT Raised to $85 at H.C. Wainwright
May 29, 2024 6:20 AM EDTH.C. Wainwright analyst Andrew Fein raised the price target on Merus N.V. (NASDAQ: MRUS) to $85.00 (from $65.00) while maintaining a Buy rating.
The analyst comments "Valuation and risks to reaching our price target. Given the recent ASCO update for petosemtamab, we are... More
Merus N.V. (MRUS) PT Raised to $80 at BofA Securities
May 29, 2024 5:13 AM EDTBofA Securities analyst Tazeen Ahmad raised the price target on Merus N.V. (NASDAQ: MRUS) to $80.00 (from $61.00) while maintaining a Buy rating.
The analyst comments "Merus reported 67% objective response rate (ORR; 1 CR, 15 PR) in 24 evaluable 1L head and neck squamous cell carcinoma (HNSCC)... More
